Macquarie Group’s Envoy Medical COCH Stock Holding History

Macquarie Group’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-344	Closed	-$1	–	1946
2024 Q1	$1	Buy	+344	New	+$1.01K	﹤0.01%	1869

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MAM

Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Macquarie Group's COCH Position: Q2 2024 in Review

Macquarie Group sold out of Envoy Medical (COCH) in Q2 2024, closing a stake of 344 shares — an estimated $1 sold.

Macquarie Group first reported a position in COCH in Q1 2024 and held it in 1 quarter. The position peaked at $1 in Q1 2024. 20 funds tracked by Wall St. Rank hold COCH as of Q2 2024.

Macquarie Group reported no remaining Envoy Medical position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 344 Envoy Medical shares in Q2 2024, an estimated $1.
Macquarie Group first reported a position in Envoy Medical in Q1 2024 and held it in 1 quarter.
Macquarie Group's Envoy Medical position peaked at $1 in Q1 2024.
20 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.